Moderna’s Covid-19 Vaccine May Reach Some by as Soon as Fall

Moderna Inc. said its experimental vaccine for Covid-19 could be available to a select few as soon as this fall, ahead of expectations for a commercial release in a year.

Stephane Bancel, the biotech’s chief executive, told Goldman Sachs on Friday that mRNA-1273 could be made available to a few, potentially health-care workers, under emergency use authorization, according to a company statement. The vaccine was developed in partnership with Moderna and the National Institute of Allergy and Infectious Diseases. Human testing started earlier this month.